ALLOZYNE is rapidly developing a number of biologic therapeutics to serve the unmet medical need in various autoimmune and CNS indications.
Who We Are
ALLOZYNE is backed by a world renown scientific advisory board and highly experienced interferon advisory board.
What We Do
ALLOZYNE has developed and optimized two different biociphering methods that enable site specific bioconjugation of any peptide or protein.
Partnering is an integral component of ALLOZYNE’s strategy to maximize the value of its technology, generate near- and mid-term revenue...